VentriGel

extracellular matrix hydrogel

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VentriGel, covering 2025-03-10 to 2025-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HLHS) [Phase 1]

See pricing